Sei Investments Co. grew its stake in CME Group Inc. (NASDAQ:CME) by 9.6% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 244,652 shares of the financial services provider’s stock after buying an additional 21,427 shares during the period. Sei Investments Co. owned approximately 0.07% of CME Group worth $33,194,000 as of its most recent SEC filing.
Several other large investors also recently made changes to their positions in CME. Fiduciary Trust Co. acquired a new stake in shares of CME Group in the second quarter worth about $105,000. Quadrant Capital Group LLC lifted its position in shares of CME Group by 13.6% in the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after buying an additional 113 shares during the last quarter. San Francisco Sentry Investment Group CA acquired a new stake in shares of CME Group in the second quarter worth about $129,000. Whittier Trust Co. lifted its position in shares of CME Group by 2.6% in the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock worth $133,000 after buying an additional 27 shares during the last quarter. Finally, People s United Financial Inc. lifted its position in shares of CME Group by 11.5% in the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after buying an additional 110 shares during the last quarter. 82.81% of the stock is owned by institutional investors.
A number of brokerages have weighed in on CME. Barclays PLC boosted their price target on CME Group from $139.00 to $149.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 10th. Wells Fargo & Company boosted their price target on CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a research report on Wednesday, October 4th. Royal Bank Of Canada boosted their price target on CME Group from $135.00 to $147.00 and gave the stock an “outperform” rating in a research report on Monday, October 16th. Citigroup Inc. boosted their price objective on CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a research report on Thursday, October 19th. Finally, BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, October 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $138.89.
In related news, Director Daniel R. Glickman sold 850 shares of the business’s stock in a transaction dated Monday, August 28th. The stock was sold at an average price of $126.65, for a total transaction of $107,652.50. Following the transaction, the director now directly owns 13,799 shares in the company, valued at $1,747,643.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Hilda Harris Piell sold 714 shares of the business’s stock in a transaction dated Wednesday, September 6th. The shares were sold at an average price of $129.00, for a total value of $92,106.00. Following the transaction, the insider now owns 28,844 shares in the company, valued at $3,720,876. The disclosure for this sale can be found here. Insiders have sold 11,339 shares of company stock worth $1,548,086 over the last 90 days. Corporate insiders own 0.57% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another domain, it was stolen and republished in violation of international copyright law. The original version of this report can be read at https://www.dispatchtribunal.com/2017/11/12/sei-investments-co-has-33-19-million-holdings-in-cme-group-inc-cme.html.
CME Group Inc. (NASDAQ CME) traded down $0.16 during midday trading on Friday, hitting $137.88. The company had a trading volume of 750,100 shares, compared to its average volume of 1,262,941. CME Group Inc. has a fifty-two week low of $111.19 and a fifty-two week high of $141.07. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. The firm has a market cap of $46,757.18, a PE ratio of 28.85, a PEG ratio of 2.82 and a beta of 0.71.
CME Group (NASDAQ:CME) last issued its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.16 by $0.03. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The firm had revenue of $890.80 million for the quarter, compared to analyst estimates of $890.22 million. During the same period in the previous year, the company posted $1.05 earnings per share. The company’s quarterly revenue was up 5.8% compared to the same quarter last year. sell-side analysts predict that CME Group Inc. will post 4.8 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Friday, December 8th will be paid a dividend of $0.66 per share. The ex-dividend date is Thursday, December 7th. This represents a $2.64 annualized dividend and a yield of 1.91%. CME Group’s dividend payout ratio is 59.86%.
About CME Group
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.